CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $13,608,809 | +79.1% | 2,170,464 | 0.0% | 0.08% | +64.0% |
Q3 2022 | $7,597,000 | +18.6% | 2,170,464 | 0.0% | 0.05% | +38.9% |
Q2 2022 | $6,403,000 | -5.1% | 2,170,464 | 0.0% | 0.04% | -7.7% |
Q1 2022 | $6,750,000 | -8.0% | 2,170,464 | 0.0% | 0.04% | +8.3% |
Q4 2021 | $7,336,000 | -7.4% | 2,170,464 | 0.0% | 0.04% | +2.9% |
Q3 2021 | $7,922,000 | -16.3% | 2,170,464 | 0.0% | 0.04% | -16.7% |
Q2 2021 | $9,463,000 | -4.0% | 2,170,464 | 0.0% | 0.04% | -2.3% |
Q1 2021 | $9,854,000 | -40.7% | 2,170,464 | -25.0% | 0.04% | -31.7% |
Q4 2020 | $16,607,000 | -29.5% | 2,893,276 | -11.0% | 0.06% | -33.0% |
Q3 2020 | $23,548,000 | +343.0% | 3,252,542 | +113.6% | 0.09% | +308.7% |
Q2 2020 | $5,315,000 | -81.8% | 1,522,792 | -73.3% | 0.02% | -88.4% |
Q3 2019 | $29,222,000 | -28.5% | 5,707,411 | 0.0% | 0.20% | -28.4% |
Q2 2019 | $40,865,000 | -46.1% | 5,707,411 | 0.0% | 0.28% | -42.7% |
Q1 2019 | $75,794,000 | +95.8% | 5,707,411 | +16.1% | 0.48% | +53.0% |
Q4 2018 | $38,702,000 | -29.0% | 4,917,700 | 0.0% | 0.32% | -11.7% |
Q3 2018 | $54,488,000 | -17.4% | 4,917,700 | 0.0% | 0.36% | -27.6% |
Q2 2018 | $65,996,000 | +29.7% | 4,917,700 | +25.5% | 0.50% | +15.1% |
Q1 2018 | $50,891,000 | +84.9% | 3,917,700 | +30.9% | 0.43% | +80.3% |
Q4 2017 | $27,524,000 | +14.1% | 2,991,775 | 0.0% | 0.24% | +21.9% |
Q3 2017 | $24,114,000 | +224.1% | 2,991,775 | +131.6% | 0.20% | +201.5% |
Q2 2017 | $7,441,000 | +22.4% | 1,291,775 | -8.6% | 0.06% | +30.0% |
Q1 2017 | $6,078,000 | +1036.1% | 1,413,499 | +357.0% | 0.05% | +900.0% |
Q4 2016 | $535,000 | – | 309,268 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |